Clinical significance of C4d deposition in stable renal allografts in the early post-transplantation period

Clinical Transplantation

Volumn 23, Issue 6, 2009, Pages 812-818

  Yoon, Hye Eun ^a   Kim, Su Hyun ^a   Kim, Jin Young ^a   Oh, Eun Jee ^a   Park, Sun Cheol ^a   Choi, Bum Soon ^a   Choi, Yeong Jin ^a   Moon, In Sung ^a   Kim, Yong Soo ^a   Yang, Chul Woo ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Allograft function; Antibody mediated rejection; C4d; Protocol biopsy; Renal transplantation

Indexed keywords

CALCINEURIN INHIBITOR; COMPLEMENT COMPONENT C4D; CORTICOSTEROID; CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; COMPLEMENT COMPONENT C4B; HLA ANTIGEN;

ADULT; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DIARRHEA; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INTERSTITIAL NEPHRITIS; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY INJURY; KIDNEY TRANSPLANTATION; LEUKOPENIA; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURVIVAL RATE; ADOLESCENT; AGED; ALLOTRANSPLANTATION; BIOPSY; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; KIDNEY; KIDNEY FAILURE, CHRONIC; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOPSY; COMPLEMENT C4B; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HLA ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 71149099497     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2008.00946.x     Document Type: Article

References (21)

1. Feucht HE, Schneeberger H, Hillebrand G. Capillary deposition of C4d complement fragment and early graft loss. Kidney Int 1993, 43:1333.
2. Collins AB, Schneeberger EE, Pascual MA. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 1999, 10:2208.
3. Mauiyyedi S, Crespo M, Collins AB. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 2002, 13:779.
4. Nickeleit V, Zeiler M, Gudat F, Thiel G, Mihatsch MJ. Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. J Am Soc Nephrol 2002, 13:242.
5. Crespo M, Pascual M, Tolkoff-Rubin N. Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics. Transplantation 2001, 71:652.
6. Kato M, Morozumi K, Takeuchi O. Complement fragment C4d deposition in peritubular capillaries in acute humoral rejection after ABO blood group-incompatible human kidney transplantation. Transplantation 2003, 75:663.
7. Herzenberg AM, Gill JS, Djurdjev O, Magil AB. C4d deposition in acute rejection: an independent long-term prognostic factor. J Am Soc Nephrol 2002, 13:234.
8. Rush DN, Karpinski ME, Nickerson P, Dancea S, Brik P, Jeffery JR. Does subclinical rejection contribute to chronic rejection in renal transplant patients?. Clin Transplant 1999, 13:441.
9. Burdick JF, Beschorner WE, Smith WJ. Characteristics of early routine renal allograft biopsies. Transplantation 1984, 38:679.
10. Mengel M, Bogers J, Bosmans JL. ESPRIT group. Incidence of C4d stain in protocol biopsies from renal allografts: results from a multicenter trial. Am J Transplant 2005, 5:1050.
11. Koo DD, Roberts IS, Quiroga I. C4d deposition in early renal allograft protocol biopsies. Transplantation 2004, 78:398.
12. Choi BS, Shin MJ, Shin SJ. Clinical significance of an early protocol biopsy in living-donor renal transplantation: ten-year experience at a single center. Am J Transplant 2005, 5:1354.
13. Racusen LC, Colvin RB, Solez K. Antibody-mediated rejection criteria-an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003, 3:708.
14. Solez K, Colvin RB, Racusen LC. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008, 8:753.
15. Yang CW, Oh EJ, Lee SB. Detection of donor-specific anti-HLA class I and II antibodies using antibody monitoring system. Transplant Proc 2006, 38:2803.
16. Troxell ML, Weintraub LA, Higgins JP, Kambham N. Comparision of C4d immunostaining methods in renal allograft biopsies. Clin J Am Soc Nephrol 2006, 1:583.
17. Nadasdy GM, Bott C, Cowden D, Pelletier R, Ferguson R, Nadasdy T. Comparative study for the detection of peritubular capillary C4d deposition in human renal allografts using different methodologies. Hum Pathol 2005, 36:1178.
18. Seemayer CA, Gaspert A, Nickeleit V, Mihatsch MJ. C4d staining of renal allograft biopsies: a comparative analysis of different staining techniques. Nephrol Dial Transplant 2007, 22:568.
19. Nickeleit V, Mihatsch MJ. Kidney transplants, antibodies and rejection: is C4d a magic marker?. Nephrol Dial Transplant 2003, 18:2232.
20. Colvin RB, Smith RN. Antibody-mediated organ-allograft rejection. Nat Rev Immunol 2005, 5:807.
21. Nickeleit V, Andreoni K. The classification and treatment of antibody-mediated renal allograft injury: where do we stand?. Kidney Int 2007, 71:7.